News archive for 2014 | www.emcdda.europa.eu

Gaps in HIV prevention expose Europe to risk of outbreaks

In Europe, decades of investment in effective HIV prevention measures targeting people who inject drugs continue to bear fruit as demonstrated by the long-term decline in HIV diagnoses related to...

Annual award ceremony to celebrate excellence in scientific writing on illicit drugs

The four winners of the 2014 EMCDDA scientific paper award will be honoured in Lisbon on 25 November at the fourth annual award ceremony hosted by the EU agency (1). The winners will receive a non-...

Third EMCDDA Reitox week

Candidate, potential candidate and neighbouring countries of the EU, preparing to collaborate with the EMCDDA, will participate in the third ‘Reitox week’ to be held in Lisbon from 25–28 November.

Pregnancy and opioid use: strategies for treatment

Illicit opioid consumption is associated with an increase in obstetric complications in pregnant women. It also brings with it a range of potential dangers for the child, both before and after birth...

Click and learn with the EMCDDA’s new-look Best practice portal

Real-life responses to drug problems come under the spotlight today as the EU drugs agency (EMCDDA) launches its revamped Best practice portal. Designed as a practical and reliable source of what...

Drug-related harms and responses in focus at annual EMCDDA expert meetings

Latest evidence in the area of drug overdose, HCV infections and HIV outbreaks among drug users will be among the topics discussed in a series of events unfolding this week at the EU drugs agency (...

Second EMDAS graduation ceremony at EMCDDA

The second group of 25 students graduating from the European Masters in Drug and Alcohol Studies (EMDAS), will receive their diplomas at a ceremony at the EMCDDA on 30 September (1). EMDAS, a project...

Four new drugs to be placed under control

Today, EU Ministers adopted a European Commission proposal to control four new psychoactive substances currently raising health concerns in Europe. With today's decision, the substances MDPV,...

EMCDDA unites expert networks in integrated approach to monitoring

‘Continuity and change: high-risk drug use and drug treatment in Europe’, is the focus of events unfolding this week at the EU drugs agency (EMCDDA) in Lisbon (1).

European Parliament President Martin Schulz to visit EU agencies in Lisbon

Newly re-elected President of the European Parliament Martin Schulz will visit the EU drugs agency (EMCDDA) and the European Maritime Safety Agency (EMSA) on 23 September, accompanied by Secretary of...

ECDC-EMCDDA mission on HIV status and hepatitis surveillance in Latvia

At the invitation of the Latvian government, and in the context of high HIV levels in the country, ECDC and the EMCDDA have joined forces to assist national experts in preventing and controlling...

Published today on World Hepatitis Day: New EMCDDA review on hepatitis C virus infection among people who inject drugs in Europe

People who inject drugs (PWID) are a key population affected by the hepatitis C virus (HCV). Treatment options are improving and may enhance prevention; however access for PWID may be poor.

Eurojust and EMCDDA pledge to boost cooperation

Exchanging strategic and technical information in the areas of drug legislation and supply was among the pledges made today in a Memorandum of Understanding (MoU) signed by the EU drugs agency (...

Third European drugs summer school opens today in Lisbon

The third European drugs summer school (EDSS) — ‘Illicit drugs in Europe: demand, supply and public policies’ — opens today in Lisbon and will run until 11 July. The initiative, organised by the...

26 June: International day against drug abuse and illicit trafficking

An estimated 28 000 lives are lost on Europe’s roads every year and a further 1.34 million people are injured (1). Many of these accidents and deaths are caused by drivers whose performance is...

EU drugs agency places six topics in the spotlight with new online analyses

The EU drugs agency (EMCDDA) releases today alongside its European Drug Report 2014: Trends and developments, six new additions to its Perspectives on drugs (PODs) series. This latest selection of...

European Drug Report out today — Europe’s drugs problem ‘increasingly complex’

Europe’s drugs problem is becoming increasingly complex with new challenges emerging that raise concerns for public health. This is according to the European Drug Report 2014: Trends and developments...

Largest multi-city study on drug wastewater analysis released today

The findings of the largest European project to date in the emerging science of wastewater analysis (WWA) are released today in an article published in Addiction (1). The project in question —...

International experts to examine latest findings in the field of new drugs

International experts gather in Rome today to examine the latest scientific research in the rapidly-changing field of novel (or new) psychoactive substances (NPS).

EU drugs agency to launch European Drug Report 2014

The EU drugs agency (EMCDDA) will be presenting its annual overview of the European drug situation on 27 May in a multilingual, multimedia information package focusing on today’s rapidly shifting...

EMCDDA and ECDC facilitate sub-regional exchange of knowledge and best practice in monitoring and preventing drug-related infections

Monitoring and responding to HIV and hepatitis C among people who inject drugs (PWID) is the focus of two new reports from the EU drugs agency (EMCDDA) and the European Centre for Disease Prevention...

Scientific Committee — elections for chair and vice chair

The EMCDDA Scientific Committee, meeting in Lisbon this week, elected its new Chair and Vice Chair for the next three years. Prof. Dr Gerhard Bühringer (Germany) was elected to the position of Chair...

Regional drug strategies across the world explored in new EMCDDA paper

The EU drugs agency (EMCDDA) has released today its first comparative analysis of regional drug strategies across the world (1). The paper explores the drug strategies and action plans adopted over...

Dangerous synthetic drugs hit the EU market

Europol and the EMCDDA have issued today early-warning notifications about two synthetic drugs that have recently been linked to serious harms in the EU.

New EMCDDA technical assistance project with ENP countries kicks off today

A new, two-year technical cooperation project between the EU drugs agency (EMCDDA) and countries of the European Neighbourhood Policy (ENP) kicks off today in Lisbon (1). The project takes place...

EMCDDA embarks on 2014 Work Programme

Following a drop in the EU subsidy to the EMCDDA this year of some 5%, 2014 promises to be a particularly challenging year for the agency. The 2014 activities are therefore framed within the context...

EU drugs agency steps up cooperation with Israel

The European Union and Israel will share information on drugs more systematically in future, thanks to a Memorandum of Understanding (MoU) signed today in Jerusalem between the EU drugs agency (...

EMCDDA hosts kick-off meeting of EC-funded Joint Action on Reducing Alcohol Related Harm

Harmful and hazardous alcohol use is one of the main causes of premature deaths and avoidable diseases in the EU today. Highlighting the importance of this issue, the European Commission is funding...

Four new drugs go under the microscope in the wake of rising health concerns

Europe has responded to rising concern over the use of four new drugs by formally requesting a scientific investigation into the health and social risks of the substances. The decision was...

Registration opens for third European drugs summer school

The University Institute of Lisbon (ISCTE-IUL) and the EU drugs agency (EMCDDA) will be joining forces again in July 2014 to hold the third European summer school on ‘Illicit drugs in Europe: demand...

Loading